ISBT on Age-Appropriate Platelet Transfusion Thresholds: New Insights from the 2025 AABB Guidelines
International Society of Blood Transfusion (ISBT) shared an enlightening post on LinkedIn:
“DID YOU KNOW? A new series by the Pediatric Subgroup of the Clinical Transfusion Working Party
In neonates, platelet transfusion thresholds are often higher than in adults due to immature hemostatic systems and a greater risk of bleeding.
Preterm infants may require platelet counts of 25,000–50,000/μL, depending on clinical condition, while stable adults typically require only 10,000–20,000/μL.
According to the 2025 AABB Guidelines, a restrictive threshold of 25,000/μL is now considered safer than the previously used liberal 50,000/μL threshold, which may increase risk.
This highlights the importance of age-appropriate transfusion strategies that reflect the unique physiology of neonates.
Reference: Metcalf RA, Nahirniak S, Guyatt G, et al. Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines. JAMA. 2025. doi:10.1001/jama.2025.7529”
Find the reference here:

Follow the newest insights in platelet science with Hemostasis Today.
-
Mar 19, 2026, 17:30UK Haemophilia Society Continues to Empower Individuals and Families Through Advocacy, Education, and Community Support – WFH
-
Mar 19, 2026, 17:20Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment
-
Mar 19, 2026, 16:49Marilena Vrana: Access, Resilience, and Policy Priorities Ahead of IPPC2026
-
Mar 19, 2026, 16:46Connie Montgomery: Celebrating Heroes of the Bleeding Disorders Community
-
Mar 19, 2026, 16:44Anita Brikman: Advancing Plasma Availability and Access to Plasma-Derived Therapies in India